3 amazing ASX growth shares that continue to stand out

Looking for growth options? Here are three to consider.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Growth investing often centres on finding businesses that can expand earnings over long periods.

That does not always mean chasing early-stage companies. Some of the strongest growth stories on the ASX today are already established, with proven models and clear pathways to further expansion.

Here are three ASX growth shares that continue to stand out.

Cheerful man in a orange shirt standing in front of an audience holding a tablet and using hand gestures to interact with the audience.

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

One company that continues to deliver strong growth is Pro Medicus.

This ASX growth share develops imaging software used by hospitals and healthcare providers. Its Visage platform is designed to handle large medical datasets with speed and efficiency.

The company's recent performance highlights the strength of its model. It delivered revenue growth of 28.4% and profit growth of 29.7% during the first half of FY 2026, supported by new contract wins and expanding global adoption.

A key driver is its long-term contract structure, particularly in the United States. These agreements can run for several years and provide recurring, high-margin revenue.

With a growing sales pipeline and increasing adoption across different medical fields, Pro Medicus continues to build on its position in a specialised but expanding market.

Temple & Webster Group Ltd (ASX: TPW)

Another ASX growth share worth looking at is Temple & Webster Group. It offers exposure to a different type of growth opportunity.

Temple & Webster operates an online-only furniture and homewares platform. It benefits from the gradual shift toward e-commerce in categories that have traditionally been dominated by physical retail.

The company's model is asset-light, allowing it to scale its product range without the costs associated with maintaining a large store network.

Growth in this segment can be uneven, influenced by housing activity and consumer spending. However, the long-term direction remains supported by increasing online penetration.

Temple & Webster's focus on data, customer experience, and product range positions it to capture a larger share of the market as buying behaviour continues to evolve.

Xero Ltd (ASX: XRO)

Xero is another ASX growth share that has built strong momentum over time.

It provides cloud-based accounting software to small and medium-sized businesses. Xero's platform sits at the centre of financial operations, making it an important part of day-to-day business activity.

The company's long-term opportunity is tied to both subscriber growth and expanding functionality. It now serves millions of users globally and continues to invest in areas such as payments and artificial intelligence.

Its strategy reflects this. Xero is focused on becoming a broader financial platform, combining accounting with payments and insights. The addition of Melio is expected to accelerate its presence in the US and improve monetisation over time.

With a large addressable market and multiple growth drivers, Xero could be a share to hold for the long term.

Motley Fool contributor James Mickleboro has positions in Pro Medicus, Temple & Webster Group, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Pro Medicus and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Half a man's face from the nose up peers over a table.
Share Market News

Why this struggling ASX tech stock could surprise investors

The best opportunities can emerge when sentiment is weakest.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

3 ASX shares that could be much bigger in 10 years

These shares could have strong futures. Here's what you need to know.

Read more »

Man on his laptop standing next to data centres.
Growth Shares

3 ASX stocks that could win big from the AI infrastructure boom

Goodman Group, Megaport, and WiseTech Global each play a different role in the AI infrastructure boom. Here's why all three…

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Growth Shares

How much could the Pro Medicus share price rise in the next year?

Pro Medicus could be one of the best shares to own from here…

Read more »

A group of people of all ages, size and colour line up against a brick wall using their devices.
Growth Shares

3 high-quality ASX 200 shares for beginners to buy and hold

For beginners, I would focus on quality businesses that can keep growing and become more valuable over time.

Read more »

long term and short term on white cubes
Growth Shares

2 top ASX shares to buy and hold for the next decade

These investments could generate significant returns.

Read more »

A woman pulls devil rock'n'roll hands and sticks her tongue out whilst headbanging, she's rocking it.
Growth Shares

This ASX tech stock has exploded 75% in a month, but can it climb higher?

The most optimistic broker sees another 90% upside ahead!

Read more »

A couple sit in their home looking at a phone screen as if discussing a financial matter.
Share Market News

2 beaten-down ASX shares to hold until 2036

These stocks look well-positioned for growth over the next decade.

Read more »